Ausiello Dennis A 4

What Happened Dennis A. Ausiello, a director of Rani Therapeutics (RANI), was granted a derivative equity award covering 123,600 shares on May 28, 2026. The Form 4 records the acquisition price as $0.00 (total $0), and the award is described in the filing as an option-like grant rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-05-28; filing date: 2026-06-01 (timely Form 4 filing).
• Instrument: Derivative award (option) for 123,600 shares; recorded price $0.00.
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnote: The award vests in full on the first anniversary of the grant, subject to continuous service; earlier full vesting occurs upon the Company's next annual stockholder meeting or a Change in Control, subject to continuous service (per the 2021 Equity Incentive Plan).
• No sale or immediate cashless exercise reported.

Context This report reflects a grant of equity-based compensation (an option award) to a director. Such grants are routine for executive and director compensation and are distinct from open-market purchases or sales — they do not by themselves indicate buying or selling sentiment. The footnote clarifies vesting and potential acceleration events (annual meeting or change in control).